| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26470-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26688-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47892-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26356-50ul | |||
![Human CD30/TNFRSF8 ELISA Kit [NBP1-91185] - Data for Human sCD30 Platinum ELISA](http://images.novusbio.com/fullsize/Human-CD30-TNFRSF8-ELISA-Kit-NBP1-91185-img0001.jpg "Human CD30/TNFRSF8 ELISA Kit [NBP1-91185] - Data for Human sCD30 Platinum ELISA")
![ELISA: Complement Component C5aR1 Antibody (3A7) [NBP3-26470] - The Binding Activity of Human Complement Component C5aR1 with Complement Component C5aR1 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized Human Complement Component C5aR1 at 10 ug/mL can bind Complement Component C5aR1 Antibody, the EC50 is 1.239-3.760 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26470_human-complement-component-c5ar1-mab-3a7-262202412272333.jpg "ELISA: Complement Component C5aR1 Antibody (3A7) [NBP3-26470] - The Binding Activity of Human Complement Component C5aR1 with Complement Component C5aR1 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized Human Complement Component C5aR1 at 10 ug/mL can bind Complement Component C5aR1 Antibody, the EC50 is 1.239-3.760 ng/mL.")
![ELISA: IL-21 ELISA Kit [NBP1-84816] - Standard curve](http://images.novusbio.com/fullsize/IL-21-ELISA-Kit-ELISA-NBP1-84816-img0001.jpg "ELISA: IL-21 ELISA Kit [NBP1-84816] - Standard curve")
![Flow Cytometry: CCR8 Antibody (2C10) [NBP3-26688] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26688_human-ccr8-mab-2c10-282202414183623.jpg "Flow Cytometry: CCR8 Antibody (2C10) [NBP3-26688] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![Flow Cytometry: Pentraxin 3/TSG-14 Antibody (10D9) [NBP3-26356] - Overlay Peak curve showing A549 cells stained with Pentraxin 3/TSG-14 Antibody (10D9) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26356_rabbit-pentraxin-3-tsg-14-mab-10d9-282202414183654.jpg "Flow Cytometry: Pentraxin 3/TSG-14 Antibody (10D9) [NBP3-26356] - Overlay Peak curve showing A549 cells stained with Pentraxin 3/TSG-14 Antibody (10D9) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![Mouse CCL2/MCP1 ELISA Kit [NBP1-92659] - Data for Mouse MCP-1 Platinum ELISA](http://images.novusbio.com/fullsize/Mouse-CCL2-MCP1-ELISA-Kit-NBP1-92659-img0001.jpg "Mouse CCL2/MCP1 ELISA Kit [NBP1-92659] - Data for Mouse MCP-1 Platinum ELISA")